In a nutshell
This study aimed to investigate how effective high-intensity focused ultrasound (HIFU) is in the treatment of prostate cancer (PCa). This study found that HIFU is an effective option to treat PCa.
Some background
HIFU (high intensity focused ultrasound; Sonablate 500) is a treatment option for prostate cancer (PCa). It uses high-frequency ultrasound energy to heat and destroy cancer cells in the prostate. A beam of ultrasound energy travels into the prostate from a probe put into the back passage. It is unclear how effective it is in the medium term.
Methods & findings
This study included 1032 patients treated with HIFU. The average age was 65 yrs. Average follow-up was 36 months.
Overall survival was 99% at 24 months. It was 97% at both 60 and 96 months. 85% of patients did not need any further treatment at 24 months. 46% of patients did not need retreatment at 96 months. Approximately 70% of patients neede a scond treatment.
The bottom line
This study found that HIFU is an effective option to treat PCa.
The fine print
This study was based on medical records. Some information was missing. This may have an impact on the results.
Published By :
BJU international
Date :
Feb 12, 2019
